Bionano Genomics, Inc. (Nasdaq: BNGO) announced a peer-reviewed study published in Molecular Therapy - Methods & Clinical Development, describing the application of optical genome mapping (OGM) to ...
A 21-day national-level training programme on “Harnessing Modern Plant Breeding Tools for Developing Climate-Resilient and ...
Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. , today announced its contribution to new research leveraging Multiplexed Assays of Variant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results